Ahola, Aila J
Lassenius, Mariann I.
Forsblom, Carol
Harjutsalo, Valma
Lehto, Markku
Groop, Per-Henrik
Article History
Received: 10 March 2017
Accepted: 19 June 2017
First Online: 26 July 2017
Competing Interests
: P.H.G. has received research grants from Eli Lilly and Roche, is an advisory board member for AbbVie, Boehringer-Ingelheim, Eli Lilly, Janssen, Medscape, Novartis, Novo Nordisk, and Sanofi. He has received lecture fees from Astra Zeneca, Boehringer-Ingelheim, Eli Lilly, Genzyme, M.S.D., Novartis, Novo Nordisk, and Sanofi. A.J.A. has received a grant from Diabetes Wellness Finland. All other authors declare that there is no conflict of interest.